San Francisco Biotechnology Network | Bay Area Life Science News, Jobs & Events
  • Home
  • About
  • News
    • SFBN Trending & Featured News & Jobs
  • SFBN Jobs
    • Submit a Job
  • Subscribe
  • Contact
News Ticker
  • [ January 30, 2023 ] Scientist: Protein Purification – Celltheon – Union City, CA San Francisco Biotech Jobs
  • [ January 30, 2023 ] AI predicts global warming will exceed 1.5 degrees in 2030s News
  • [ January 30, 2023 ] Oracle executive Troy Tazbaz named new FDA director of digital health News
  • [ January 30, 2023 ] Paradigm Announces Acquisition of Welvie News
  • [ January 30, 2023 ] Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care News
HomeNewsRoche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea

Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea

January 31, 2022 San Francisco Biotechnology Network News News Comments Off on Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron's dominant Eylea kdunleavy Mon, 01/31/2022 - 09:52

Click to view original post

Previous

Power Knot Collaborates with Microsoft to Create the First Solar Powered Biodigester

Next

iBIO increases support for hands-on STEM with New Phase of its STEM Kit Program

POST A JOB

Featured Jobs

Follow Us On Twitter

Tweets by @sdbn

Networking & Associations

  • AWIS-SF
  • Bay Area Society for Neuroscience
  • BioScience Forum
  • California Life Sciences Association
  • Meetup: Bay Area Life Tech
  • Meetup: East Bay Bio Network
  • Meetup: San Francisco Biotechnology Meetup
  • Meetup: San Francisco Life Science Professionals
  • Parenteral Drug Association West Coast Chapter
  • SynBioBeta
  • Women in Bio San Francisco

Copyright © 2022 Biotech Networks, LLC

Get Biotech Networks Briefs in Your Inbox: Trending News & Featured Jobs